Lethal Mycobacterium massiliense sepsis, Italy

Emerging Infectious Diseases

Volumn 14, Issue 6, 2008, Pages 984-985

  Tortoli, Enrico ^a   Gabini, Rita ^b   Galanti, Irene ^b   Mariottini, Alessandro ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b IRCCS POLICLINICO SAN DONATO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; AZATHIOPRINE; CEFOXITIN; CEFTRIAXONE; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; CYCLOSPORIN; DNA 16S; FLUCONAZOLE; GATIFLOXACIN; IMIPENEM; IMMUNOSUPPRESSIVE AGENT; LEVOFLOXACIN; LINEZOLID; PIPERACILLIN PLUS TAZOBACTAM; PREDNISOLONE; RNA POLYMERASE BETA SUBUNIT; TOBRAMYCIN; TUBERCULOSTATIC AGENT;

ADULT; ANAMNESIS; ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; CASE REPORT; CLINICAL FEATURE; DISEASE EXACERBATION; DISEASE PREDISPOSITION; FEMALE; GENE SEQUENCE; HUMAN; INTENSIVE CARE UNIT; ITALY; JOINT PROSTHESIS; LABORATORY TEST; LETTER; LEUKOPENIA; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NEUTROPHIL COUNT; NUCLEOTIDE SEQUENCE; SEPTIC SHOCK; TUBERCULOSIS;

EID: 45249109770     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1406.080194     Document Type: Letter

References (10)

1. Böddinghaus B, Rogall T, Flohr T, Blöcker H, Böttger EC. Detection and identification of mycobacteria by amplification of rRNA. J Clin Microbiol. 1990;28:1751-9.
2. Adékambi T, Colson P, Drancourt M. rpoB-based identification of nonpigmented and late-pigmenting rapidly growing mycobacteria. J Clin Microbiol. 2003;41:5699-708.
3. Delaney V, Sumrani N, Hong JH, Sommer B. Mycobacterial infections in renal allograft recipients. Transplant Proc. 1993;25:2288-9.
4. Branger B, Gouby A, Oulès R, Barducci JP, Mourad G, Fourcade J, et al. Mycobacterium haemophilum and Mycobacterium xenopi associated infection in a renal transplant patient. Clin Nephrol. 1985;23:46-9.
5. Adékambi T, Reynaud-Gaubert M, Greub G, Gevaudan MJ, La Scola B, Raoult D, et al. Amoebal coculture of "Mycobacterium massiliense" sp. nov. from the sputum of a patient with hemoptoic pneumonia. J Clin Microbiol. 2004;42:5493-501.
6. Simmon KE, Pounder JI, Greene JN, Walsh F, Anderson CM, Cohen S, et al. Identification of an emerging pathogen, Mycobacterium massiliense, by rpoB sequencing of clinical isolates collected in the United States. J Clin Microbiol. 2007;45:1978-80.
7. Kim HY, Yun YJ, Park CG, Lee BH, Cho YK, Park BJ, et al. Outbreak of Mycobacterium massiliense infection associated with intramuscular injections. J Clin Microbiol. 2007;45:3127-30.
8. Viana-Niero C, Lima KV, Lopes ML, da Silva Rabello MC, Marsola LR, Brilhante VC, et al. Molecular characterization of Mycobacterium massiliense and Mycobacterium bolletii in outbreaks of infections after laparoscopic surgeries and cosmetic procedures. J Clin Microbiol. 2008;46:850-5.
9. Clinical and Laboratory Standards Institute (CLSI). Susceptibility testing of Mycobacteria, Nocardia, and other aerobic actinomycetes: approved standard M24-A. Wayne (PA): The Institute; 2003.
10. Brown-Elliott BA, Wallace RJ Jr. Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev. 2002;15:716-46.